At a glance

ClinicalIndex Comparison Record

Phase 4Completed· 48 enrolled

Drug / intervention

Hydroxyethyl Starch +1 moredrug

Likely dose

Hydroxyethyl Starch 30mlfrom record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00542516

NCT00542516Phase 4Completed

Compare CT.gov

Comparison Between Two Techniques of Volemic Expansion in Hip Replacement Arthroplasty: Hydroxyethyl Starch Versus Ringer's Lactate

University of Sao Paulo·interventional·Posted Oct 11, 2007·Updated Feb 19, 2009

In Brief

A Phase 4 clinical trial evaluating Hydroxyethyl Starch and Ringer's lactate for Hip Replacement Arthroplasty. Completed, enrolled 48 participants across 1 site.

Detailed Summary

Currently the most use solution to volemic reposition in hip replacement arthroplasty is the crystalloid solution. This trial intends to compare two different volemic replacements: HES and Ringer's lactate. This research has been analyzing hemodynamic parameters and the coagulation status before and after the pre-expansion with the solutions above mentioned.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsHip Replacement Arthroplasty

CountriesBrazil

Collaborators--

Timeline

Phase 4CompletedFinished

200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Enrollment StartSep 2006

First PostedOct 2007

Study CompletionNov 2008

TodayJul 2026

First PostedOct 11, 2007

Enrollment StartSep 1, 2006

Study CompletionNov 1, 2008

TodayJul 2, 2026

Posted 18.7 years ago

Interventions

Hydroxyethyl Starchdrug

Dosage: 30ml/kg; frequency: one time; duration: 60min

Ringer's lactatedrug

Dosage: 30ml/kg; frequency: one time; duration: 60min.After 10ml-kg-h both groups